07:00 , Sep 19, 2011 |  BC Week In Review  |  Company News

Pro Bono Bio sales and marketing update

Pro Bono Bio, a newco developing products based on its Sequessome nanotechnology, said it will market its products in different geographic areas using a tiered pricing system based on a region's ability to pay. Its...
07:00 , Sep 19, 2011 |  BioCentury  |  Finance

Celtic rolls its own

Celtic rolls its own Celtic Pharmaceutical Holdings has rolled up all the investments and cash from its funds - about $700 million in all - into a single company. The newco, Pro Bono Bio ,...
00:51 , Sep 13, 2011 |  BC Extra  |  Company News

Celtic Pharma, RUSNANO form nanotech-based newco

The Russian Corp. of Nanotechnologies and Celtic Pharma Holdings launched Pro Bono Bio , a newco developing products based on its Sequessome nanotechnology. Celtic Pharma's John Mayo is CEO of Pro Bono, which is headquartered...